Hutch News
Results per Page:
Naïve and memory T cells elicit a convergent response to CMV
From the Boeckh, Bradley, and Prlic Labs, a collaboration between the Vaccine and Infectious Disease, Clinical Research, and Public Health Sciences Divisions
From the freezers, a speedier way to evaluate antiviral drugs
Lookback research showed today’s ‘viral load’ measurements and machine learning quickly mirrored outcomes of older, slower trials
Dr. Anna Wald lauded by Infectious Diseases Society
Virologist will deliver prestigious John F. Enders Lecture during annual conference
New study will track workers at high risk for coronavirus
Volunteers to provide regular samples to help close knowledge gaps in how COVID-19 spreads undetected
Infectious Diseases Society to honor Dr. Michael Boeckh
Hutch virus expert to deliver John F. Enders Lecture at Washington, D.C., conference
Infections in immune-compromised patients: 5 new frontiers
Infectious disease experts gather in Seattle to find solutions for patients with compromised immunity
Rethinking an old viral foe
Why does a common virus plague bone marrow transplant patients? New study challenges dogma, opens door to new therapies.
Predicting lower respiratory disease in transplant patients
From the Boeckh lab, Vaccine and Infectious Disease Division
Dr. Joshua Hill receives Amy Strelzer Manasevit grant award
Award will help fund ‘paradigm shift’ in diagnosing post-transplant infections
Physician assistant Debra Mattson to retire May 24
She has been the historian — and the heart —of the Infectious Disease Consult Service
With approval of new CMV drug for transplant patients, a legacy continues
Tissue samples from a clinical trial conducted decades ago yield new insights and treatments
Dr. Steve Pergam receives Dr. Ali Al-Johani Award
An expert in infection prevention who is also a 'passionate patient care advocate and an outstanding physician'
A heavy load triggers shedding
From the Boeckh Laboratory, Vaccine and Infectious Disease
Science without borders
At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases
Good News: Stemming the harm common virus causes in critically ill patients
Celebrating faculty and staff achievements
Good News: Fred Hutch scientists to develop bioassay for ovarian cancer for new NCI initiative
Celebrating faculty and staff achievements
What we can learn about global flu evolution from individual infections
Study of 10-year-old flu samples finds virus’s evolution in individual transplant patients partially mirrors later global trends
Is the common cold a risk for hematopoietic cell transplant recipients?
From the Boeckh laboratory, Vaccine and Infectious Disease Division
Good News: iCMLf honors Dr. Jerald Radich, and more
Celebrating faculty and staff achievements
Common cold can be surprisingly dangerous for transplant patients
Study shows typically ‘mild’ respiratory virus can turn into deadly pneumonia in this vulnerable population, points to need for effective meds, better prevention